Cardea Bio (part of Paragraf®) is founded in 2019, operates from its headquarter in 8969 Kenamar Dr. Suite 104 San Diego, California 92121, US. The company operates in the Manufacturing, Industrial Machinery & Computer equipment sector.
Cardea Bio (part of Paragraf®) specializes in Biocompatible semiconductor technology, Biosignal processing, Graphene electronic device manufacturing, Scalable semiconductor production, and offers services including BPU™ (Biosignal Processing Unit), Biocompatible semiconductors, and Biosensing devices.
Total Rounds
US$ 1.1M
Last Round
US$ 1.1M
Rounds
1
Investors
Bill & Melinda Gates Foundation